MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.

Understanding the underlying molecular mechanisms of defined cancers is crucial for effective personalized therapies. Translocations of the mixed-lineage leukemia (MLL) gene produce fusion proteins such as MLL-AF4 that disrupt epigenetic pathways and cause poor-prognosis leukemias. Here, we find tha...

Bibliografske podrobnosti
Main Authors:	Kerry, J, Godfrey, L, Repapi, E, Tapia, M, Blackledge, N, Ma, H, Ballabio, E, O'Byrne, S, Ponthan, F, Heidenreich, O, Roy, A, Roberts, I, Konopleva, M, Klose, R, Geng, H, Milne, T
Format:	Journal article
Jezik:	English
Izdano:	Cell Press 2017

Podobne knjige/članki

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.
od: Godfrey, L, et al.
Izdano: (2016)

RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
od: Wilkinson, A, et al.
Izdano: (2013)

RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.
od: Wilkinson, A, et al.
Izdano: (2013)

Next generation sequencing techniques reveal molecular mechanisms of MYB regulation and function in MLL-AF9 Leukemia
od: Lau, I, et al.
Izdano: (2017)

PAF1 and FACT cooperate with MLL-AF4 to drive enhancer activity in leukemia
od: Milne, T, et al.
Izdano: (2022)

The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia
od: Numata, A, et al.
Izdano: (2018)

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
od: Crump, NT, et al.
Izdano: (2023)

The function of PRC2 in MLL-AF4 acute lymphoid leukaemia
od: Tapia, M
Izdano: (2015)

The role of DOT1L in MLL-AF4 leukaemia
od: Godfrey, L
Izdano: (2018)

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.
od: Ballabio, E, et al.
Izdano: (2012)

A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program
od: Rice, S, et al.
Izdano: (2021)

H3K79me2/3 controls enhancer–promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
od: Godfrey, L, et al.
Izdano: (2020)

The role of MYB in MLL-AF9 leukaemia
od: Lau, IJ
Izdano: (2019)

Machine learning methods for next generation sequencing data: applications to MLL-AF4 leukemia and demographic inference
od: Cole, CB
Izdano: (2021)

Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia.
od: Collins, E, et al.
Izdano: (2002)

MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199
od: Benito, J, et al.
Izdano: (2015)

Genetic screening to investigate treatment resistance in MLL-rearranged leukemia
od: Jamilly, M
Izdano: (2019)

Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis.
od: Daser, A, et al.
Izdano: (2004)

A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology.
od: Metzler, M, et al.
Izdano: (2006)

TET1 plays an essential oncogenic role in MLL-rearranged leukemia
od: Jaenisch, Rudolf, et al.
Izdano: (2014)

The MLL family of proteins in normal development and disease
od: Milne, TA
Izdano: (2020)

Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development.
od: Collins, E, et al.
Izdano: (2000)

Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
od: Biswas, D, et al.
Izdano: (2011)

A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 Acute Lymphocytic Leukemia cells
od: Kotani, Ai, et al.
Izdano: (2012)

Fusi gena Tel-Aml1, BCR-ABL, E2A-PBX1 dan MLL-Af4 sebagai faktor prognosis leukemia limfoblastik akut
od: , MULATSIH, Sri, et al.
Izdano: (2010)

Preclinical modeling of cytosine arabinoside response in Mll-Enl translocator mouse leukemias.
od: Cano, F, et al.
Izdano: (2008)

Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis.
od: Milne, T, et al.
Izdano: (2010)

Multiple Interactions Recruit MLL1 and MLL1 Fusion Proteins to the HOXA9 Locus in Leukemogenesis
od: Milne, T, et al.
Izdano: (2010)

MLL5 expression as a biomarker for DNA hypermethylation and sensitivity to epigenetic therapy.
od: Milne, T
Izdano: (2014)

Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.
od: Johnson, J, et al.
Izdano: (2003)

Pareto rules for malaria super-spreaders and super-spreading
od: Cooper, L, et al.
Izdano: (2019)

Why are so many MLL lysine methyltransferases required for normal mammalian development?
od: Crump, N, et al.
Izdano: (2019)

BET inhibition disrupts transcription but retains enhancer-promoter contact
od: Nicholas Crump, et al.
Izdano: (2019)

Developmentally regulated molecular programmes in human fetal haematopoietic cells cooperate with MLL-AF4 to drive infant acute lymphoblastic leukaemia
od: Rice, S
Izdano: (2021)

Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax
od: Fidyt, K, et al.
Izdano: (2022)

Dimerization of MLL fusion proteins immortalizes hematopoietic cells.
od: Martin, M, et al.
Izdano: (2003)

Interaction of MLL amino terminal sequences with menin is required for transformation.
od: Caslini, C, et al.
Izdano: (2007)

Genome-wide analyses reveal new insights into MLL fusion protein recruitment mechanisms
od: Kerry, J
Izdano: (2015)

MLL associates specifically with a subset of transcriptionally active target genes.
od: Milne, T, et al.
Izdano: (2005)

MLL targets SET domain methyltransferase activity to Hox gene promoters.
od: Milne, T, et al.
Izdano: (2002)